mucormycosis

Letter to the Editor
Immunosuppressed Adult Zebrafish Model of Mucormycosis
A. M. Tatara, S. Wurster, C. R. Lockworth, N. D. Albert, T. J. Walsh, A. G. Mikos, G. T. Eisenhoffer, D. P. Kontoyiannis
Letter to the Editor
In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis
Evgenii Shumilov, Ulrike Bacher, Christina Perske, Alexander Mohr, Helmut Eiffert, Justin Hasenkamp, Lorenz Trümper, Gerald G. Wulf, Philipp Ströbel, Ashraf S. Ibrahim, Vivek Venkataramani
Experimental Therapeutics
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection
Teclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, Nathan P. Wiederhold, Edward P. Garvey, William J. Hoekstra, Robert J. Schotzinger, Thomas F. Patterson, Scott G. Filler, Ashraf S. Ibrahim
Open Access

Pharmacology
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole
Laura L. Kovanda, Francisco M. Marty, Johan Maertens, Amit V. Desai, Christopher Lademacher, Marc Engelhardt, Qiaoyang Lu, William W. Hope
Experimental Therapeutics
Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis
Teclegiorgis Gebremariam, Sondus Alkhazraji, Clara Baldin, Laura Kovanda, Nathan P. Wiederhold, Ashraf S. Ibrahim

Main menu